Medicamen Biotech Complete Financial Statements
MEDICAMEQ • Review detailed financials to uncover trends, confirm thesis & journal trades
7 Years of Data
2025 - 2019
Complete Financial Data Export
Export complete financial statements for Medicamen Biotech (MEDICAMEQ).
Downloads include all available records across all periods.
For market performance, see the
MEDICAMEQ stock price today
.
Profitability Ratios
Net Profit Margin
4.17%
2025 data
EBITDA Margin
12.50%
2025 data
Operating Margin
11.00%
2025 data
Return on Assets
0.67%
2025 data
Return on Equity
0.94%
2025 data
Balance Sheet Ratios
Current Ratio
27.50
2025 data
Debt to Equity
1.39
2025 data
Equity Ratio
71.72%
2025 data
Asset Turnover
0.16
2025 data
Year-over-Year Growth Analysis
Comparing Sept 2024 vs Sept 2025
Revenue Growth
+6.7%
Year-over-Year
Net Profit Growth
+100.0%
Year-over-Year
Expense Growth
+7.7%
Year-over-Year
Assets Growth
+0.7%
Year-over-Year
Equity Growth
+2.9%
Year-over-Year
Liabilities Growth
+0.7%
Year-over-Year
Operating Cash Flow Growth
-14.3%
Year-over-Year
Investing Cash Flow Growth
+83.3%
Year-over-Year
Financing Cash Flow Growth
-133.3%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | Jun 2024 | Dec 2024 | Sept 2023 | Mar 2023 | Jun 2023 | Dec 2023 | Sept 2022 | Mar 2022 | Jun 2022 | Dec 2022 | Sept 2021 | Mar 2021 | Jun 2021 | Dec 2021 | Sept 2020 | Mar 2020 | Jun 2020 | Dec 2020 | Sept 2019 | Mar 2019 | Jun 2019 | Dec 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 48 | 35 | 44 | 45 | 48 | 44 | 45 | 44 | 39 | 42 | 47 | 34 | 23 | 34 | 36 | 33 | 22 | 28 | 34 | 31 | 25 | 28 | 33 | 36 | 24 | 31 | 36 |
| Expenses | 42 | 31 | 38 | 39 | 42 | 40 | 38 | 39 | 32 | 35 | 42 | 28 | 18 | 27 | 30 | 26 | 17 | 22 | 26 | 25 | 21 | 24 | 28 | 30 | 20 | 26 | 30 |
| EBITDA | 6 | 4 | 5 | 6 | 6 | 4 | 7 | 5 | 7 | 7 | 6 | 6 | 5 | 7 | 7 | 7 | 5 | 6 | 7 | 6 | 4 | 4 | 5 | 6 | 4 | 5 | 6 |
| Operating Profit Margin % | 11.00% | -5.00% | 11.00% | 12.00% | 12.00% | 8.00% | 15.00% | 11.00% | 17.00% | 17.00% | 11.00% | 17.00% | 22.00% | 17.00% | 17.00% | 19.00% | 20.00% | 22.00% | 19.00% | 18.00% | 13.00% | 15.00% | 16.00% | 16.00% | 18.00% | 16.00% | 15.00% |
| Depreciation | 2 | 1 | 2 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 0 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Interest | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 3 | 3 | 2 | 2 | 3 | 2 | 4 | 3 | 4 | 5 | 3 | 4 | 3 | 4 | 4 | 5 | 4 | 5 | 5 | 5 | 3 | 3 | 4 | 5 | 4 | 4 | 5 |
| Tax | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Net Profit | 2 | 2 | 2 | 1 | 2 | 1 | 3 | 2 | 4 | 4 | 2 | 4 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 3 | 3 | 2 | 3 | 4 | 2 | 3 | 4 |
| Earnings Per Share (₹) | 1.56 | 1.47 | 1.18 | 0.71 | 1.61 | 0.63 | 2.30 | 1.17 | 3.03 | 3.12 | 1.60 | 2.85 | 2.25 | 2.94 | 2.98 | 3.46 | 2.99 | 3.40 | 3.09 | 2.64 | 2.05 | 1.84 | 2.47 | 3.18 | 2.06 | 2.75 | 3.05 |
Related Pages for Medicamen Biotech
Additional stock information and data for MEDICAMEQ
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Total Assets | 297 | 295 | 279 | 226 | 194 | 181 | 137 |
| Current Assets | 165 | 160 | 163 | 123 | 96 | 104 | 96 |
| Fixed Assets | 87 | 92 | 93 | 93 | 90 | 34 | 24 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 | 41 | 15 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 210 | 203 | 186 | 133 | 104 | 107 | 98 |
| LIABILITIES | |||||||
| Total Liabilities | 297 | 295 | 279 | 226 | 194 | 181 | 137 |
| Current Liabilities | 6 | 3 | 3 | 7 | 8 | 4 | 1 |
| Non-Current Liabilities | |||||||
| SHAREHOLDERS' EQUITY | |||||||
| Total Equity | 213 | 207 | 193 | 147 | 133 | 121 | 87 |
| Share Capital | 13 | 13 | 13 | 12 | 12 | 12 | 12 |
| Reserves & Surplus | 200 | 194 | 178 | 134 | 121 | 109 | 75 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 |
|---|---|---|---|---|---|---|---|
| Operating Activities | -8 | -7 | -6 | 4 | 13 | 13 | 4 |
| Investing Activities | -1 | -6 | -6 | -9 | -18 | -37 | -15 |
| Financing Activities | -2 | 6 | 29 | 4 | 6 | 19 | -4 |
| Net Cash Flow | -11 | -6 | 17 | 0 | 1 | -5 | -14 |